SecBot SecBot
COURT-RULING ·Filed Jul 21, 2026

ALGN

ALIGN TECHNOLOGY INC
BULLISH
Impact 6/10
Horizonimmediate Processed3mo ago CourtCourt Ruling · govinfo.gov
Actionable Insight ▲ Bullish

This ruling eliminates a meaningful IP overhang for Align's core Invisalign business. With the patents invalidated, Dental Monitoring cannot assert them against Align or its customers. The decision, combined with the earlier subject-matter eligibility ruling on July 7, 2026, effectively ends this patent threat. Monitor for any potential Dental Monitoring petition for certiorari (unlikely given nonprecedential status) and for any remaining IPR proceedings involving other Dental Monitoring patents.

DirectionBullish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$172.46
T+0 close · Jul 22, 2026 · via day close
Latest settled
−13.41%
T+60 · $149.34
Vs SPY
−16.67%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 22 $172.46entry
  2. T+1 · 4mo ago −2.45%α −1.21% · $168.24
  3. T+5 · 4mo ago +4.42%α +6.82% · $180.08
  4. T+20 · 3mo ago −5.46%α −8.36% · $163.04
  5. T+60 · 5w ago −13.41%α −16.67% · $149.34
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The Federal Circuit affirmed PTAB decisions invalidating key claims of two Dental Monitoring patents (’248 and ’945) covering methods for assessing orthodontic aligner fit using deep learning and image processing. Align Technology successfully challenged these patents as obvious over prior art, including its own Invisalign clinical guide. This removes a potential IP threat to Align's core clear aligner business and eliminates litigation risk from Dental Monitoring's patent assertions.

Court Ruling Details

Ruling Date
Jul 21, 2026
Court
United States Court of Appeals for the Federal Circuit
Court Level
Appellate
Judge
Lourie
Case Type
patent
Ruling Type
final judgment
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • Federal Circuit affirmed PTAB rulings that claims 1, 2, 4, 7–8, 13–16 of US Patent 11,049,248 and claims 1, 2, 4–6 of US Patent 11,109,945 were unpatentable as obvious
  • Claims 1 and 14 of the ’248 patent had already been invalidated as directed to ineligible subject matter in a separate July 7, 2026 Federal Circuit ruling
  • The prior art combination included Align's own Invisalign clinic monitoring guide, which was cited as teaching aligner fit assessment
  • Dental Monitoring's arguments that prior art references taught away from deep learning and that a key reference was not publicly accessible were rejected
  • Align's expert Dr. Hassan Foroosh was deemed qualified as a skilled artisan despite lacking dentistry experience

Financial Impact

Removes potential patent infringement liability and licensing costs for Align's Invisalign product line; no damages were awarded or sought in this IPR proceeding

ip_risklegal_exposure

Risk Factors

  • Dental Monitoring could petition for certiorari, though nonprecedential Federal Circuit IPR affirmances are rarely reviewed by SCOTUS
  • Other Dental Monitoring patents not challenged in these IPRs could still be asserted against Align
  • The ruling does not affect any pending district court litigation between the parties that may involve different patents

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
71% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 2 court opinions.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-fb6efb3d43-ALGN
COURT-RULING Data (Synthetic)court-1cdd68bc07-ALGN

Track record

19 reports on ALGN

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +12.30% at T+60 after the Aug 3, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $168.32 Now $165.98 −1.39% settles Dec 14
  2. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $172.08 Now $165.98 −3.54% settles Dec 10
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $166.00 Now $165.98 −0.01% settles Dec 7
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $159.37 Now $165.98 +4.15% settles Dec 4
  5. Nov 2, 202614d ago 3 Neutral 1/10 Entry $151.58 Now $165.98 +9.50% settles Dec 2
  6. Oct 28, 202619d ago 8-K Neutral 3/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
  7. Oct 28, 202619d ago 8-K Neutral 5/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
  8. Oct 21, 202627d ago PTAB Trial Mixed 6/10 Entry $155.51 Now $165.98 +6.73% settles Nov 19
  9. Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $148.90 to $165.98 Now $165.98 −11.47% ▼ −11.47% −14.93% vs SPY
  10. Aug 31, 202611w ago 8-K Neutral 2/10 Entry $154.96 to $145.35 Now $165.98 +7.11% ▼ −6.20% −6.52% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (9h 57m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 22, 2026